Cefoselis is used for the treatment of moderate to severe infections caused by susceptible bacteria, including bloodstream infections, lower respiratory tract infections (such as pneumonia), febrile neutropenia, and genitourinary tract infections. It exhibits potent antibacterial activity against a broad spectrum of Gram-positive and Gram-negative pathogens, including those producing chromosomally mediated inducible AmpC β-lactamases. Cefoselis can penetrate the blood-brain barrier and demonstrates strong in vitro activity against Haemophilus influenzae, Moraxella catarrhalis, methicillin-susceptible Staphylococcus aureus (MSSA), and methicillin-susceptible coagulase-negative staphylococci (MSCNS).